← All status records
Educational regulatory-status record
Semaglutide compounded preparation
Compoundedregulatory categoryCompounded; not an FDA-approved finished product
This page explains an official classification boundary. It is not a recommendation, suitability assessment, or commercial listing.
Official status explanation
FDA states that compounded drugs are not FDA-approved. A compounded preparation is a product category and process description, not a finding that a particular preparation has been reviewed or approved.
Record freshness: within the review interval · last reviewed 2026-08-18 · review due 2026-09-17
What this record does not conclude
- It does not establish FDA review of safety, effectiveness, or quality for a particular preparation.
- It does not establish that a compounded preparation is the same as an FDA-approved finished product.
- It does not establish personal suitability or a clinical recommendation.
Source and review trail
- Source
- Compounding and the FDA: Questions and Answers
- Source type
- FDA
- Source date
- Page date not stated
- Checked
- 2026-08-18
- Review rule
- Human review required within 30 days and after material official change.
There are no vendors, purchase links, product destinations, or personalized selection tools on this educational page.